Paying users zone. Data is hidden behind: .
Get 1-month access to Becton, Dickinson & Co. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Becton, Dickinson & Co. pages available today for free:
Analysis of Profitability Ratios
Quarterly Data
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Becton, Dickinson & Co., profitability ratios (quarterly data)
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Becton, Dickinson & Co.’s gross profit margin ratio deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Becton, Dickinson & Co.’s operating profit margin ratio improved from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021. |
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Becton, Dickinson & Co.’s net profit margin ratio deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Becton, Dickinson & Co.’s ROE deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
ROA | A profitability ratio calculated as net income divided by total assets. | Becton, Dickinson & Co.’s ROA deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Gross Profit Margin
Becton, Dickinson & Co., gross profit margin calculation (quarterly data)
Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||
Gross profit | |||||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||
Profitability Ratio | |||||||||||||||||||||||||||||||||
Gross profit margin1 | |||||||||||||||||||||||||||||||||
Benchmarks | |||||||||||||||||||||||||||||||||
Gross Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||
Boston Scientific Corp. | |||||||||||||||||||||||||||||||||
Danaher Corp. | |||||||||||||||||||||||||||||||||
Edwards Lifesciences Corp. | |||||||||||||||||||||||||||||||||
Intuitive Surgical Inc. | |||||||||||||||||||||||||||||||||
Medtronic PLC | |||||||||||||||||||||||||||||||||
Stryker Corp. | |||||||||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | |||||||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
1 Q1 2021 Calculation
Gross profit margin = 100
× (Gross profitQ1 2021
+ Gross profitQ4 2020
+ Gross profitQ3 2020
+ Gross profitQ2 2020)
÷ (RevenuesQ1 2021
+ RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Becton, Dickinson & Co.’s gross profit margin ratio deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Operating Profit Margin
Becton, Dickinson & Co., operating profit margin calculation (quarterly data)
Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||
Operating income (loss) | |||||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||
Profitability Ratio | |||||||||||||||||||||||||||||||||
Operating profit margin1 | |||||||||||||||||||||||||||||||||
Benchmarks | |||||||||||||||||||||||||||||||||
Operating Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||
Boston Scientific Corp. | |||||||||||||||||||||||||||||||||
Danaher Corp. | |||||||||||||||||||||||||||||||||
Edwards Lifesciences Corp. | |||||||||||||||||||||||||||||||||
Intuitive Surgical Inc. | |||||||||||||||||||||||||||||||||
Medtronic PLC | |||||||||||||||||||||||||||||||||
Stryker Corp. | |||||||||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | |||||||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
1 Q1 2021 Calculation
Operating profit margin = 100
× (Operating income (loss)Q1 2021
+ Operating income (loss)Q4 2020
+ Operating income (loss)Q3 2020
+ Operating income (loss)Q2 2020)
÷ (RevenuesQ1 2021
+ RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Becton, Dickinson & Co.’s operating profit margin ratio improved from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021. |
Net Profit Margin
Becton, Dickinson & Co., net profit margin calculation (quarterly data)
Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||
Net income (loss) | |||||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||
Profitability Ratio | |||||||||||||||||||||||||||||||||
Net profit margin1 | |||||||||||||||||||||||||||||||||
Benchmarks | |||||||||||||||||||||||||||||||||
Net Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||
Boston Scientific Corp. | |||||||||||||||||||||||||||||||||
Danaher Corp. | |||||||||||||||||||||||||||||||||
Edwards Lifesciences Corp. | |||||||||||||||||||||||||||||||||
Intuitive Surgical Inc. | |||||||||||||||||||||||||||||||||
Medtronic PLC | |||||||||||||||||||||||||||||||||
Stryker Corp. | |||||||||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | |||||||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
1 Q1 2021 Calculation
Net profit margin = 100
× (Net income (loss)Q1 2021
+ Net income (loss)Q4 2020
+ Net income (loss)Q3 2020
+ Net income (loss)Q2 2020)
÷ (RevenuesQ1 2021
+ RevenuesQ4 2020
+ RevenuesQ3 2020
+ RevenuesQ2 2020)
= 100 × ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Becton, Dickinson & Co.’s net profit margin ratio deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Return on Equity (ROE)
Becton, Dickinson & Co., ROE calculation (quarterly data)
Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||
Net income (loss) | |||||||||||||||||||||||||||||||||
Shareholders’ equity | |||||||||||||||||||||||||||||||||
Profitability Ratio | |||||||||||||||||||||||||||||||||
ROE1 | |||||||||||||||||||||||||||||||||
Benchmarks | |||||||||||||||||||||||||||||||||
ROE, Competitors2 | |||||||||||||||||||||||||||||||||
Boston Scientific Corp. | |||||||||||||||||||||||||||||||||
Danaher Corp. | |||||||||||||||||||||||||||||||||
Edwards Lifesciences Corp. | |||||||||||||||||||||||||||||||||
Intuitive Surgical Inc. | |||||||||||||||||||||||||||||||||
Medtronic PLC | |||||||||||||||||||||||||||||||||
Stryker Corp. | |||||||||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | |||||||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
1 Q1 2021 Calculation
ROE = 100
× (Net income (loss)Q1 2021
+ Net income (loss)Q4 2020
+ Net income (loss)Q3 2020
+ Net income (loss)Q2 2020)
÷ Shareholders’ equity
= 100 × ( + + + )
÷ =
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Becton, Dickinson & Co.’s ROE deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |
Return on Assets (ROA)
Becton, Dickinson & Co., ROA calculation (quarterly data)
Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||
Net income (loss) | |||||||||||||||||||||||||||||||||
Total assets | |||||||||||||||||||||||||||||||||
Profitability Ratio | |||||||||||||||||||||||||||||||||
ROA1 | |||||||||||||||||||||||||||||||||
Benchmarks | |||||||||||||||||||||||||||||||||
ROA, Competitors2 | |||||||||||||||||||||||||||||||||
Boston Scientific Corp. | |||||||||||||||||||||||||||||||||
Danaher Corp. | |||||||||||||||||||||||||||||||||
Edwards Lifesciences Corp. | |||||||||||||||||||||||||||||||||
Intuitive Surgical Inc. | |||||||||||||||||||||||||||||||||
Medtronic PLC | |||||||||||||||||||||||||||||||||
Stryker Corp. | |||||||||||||||||||||||||||||||||
Thermo Fisher Scientific Inc. | |||||||||||||||||||||||||||||||||
UnitedHealth Group Inc. |
Based on: 10-Q (filing date: 2021-02-04), 10-K (filing date: 2020-11-25), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06).
1 Q1 2021 Calculation
ROA = 100
× (Net income (loss)Q1 2021
+ Net income (loss)Q4 2020
+ Net income (loss)Q3 2020
+ Net income (loss)Q2 2020)
÷ Total assets
= 100 × ( + + + )
÷ =
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROA | A profitability ratio calculated as net income divided by total assets. | Becton, Dickinson & Co.’s ROA deteriorated from Q3 2020 to Q4 2020 but then improved from Q4 2020 to Q1 2021 exceeding Q3 2020 level. |